Randall Schatzman Net Worth & Insider Trades

Randall Schatzman - Chief Executive Officer, Bolt Biotherapeutics, Inc

As of February 28, 2023

What is Randall Schatzman's Net Worth?

The current estimated net worth of Bolt Biotherapeutics, Inc's Chief Executive Officer, Randall Schatzman, is estimated to be about $11.74M . Randall Schatzman owns about 1,500 units of Bolt Biotherapeutics, Inc common stock. In the last 2 years at Bolt Biotherapeutics, Inc, Randall Schatzman has sold an estimated value of $0 worth.

What is Randall Schatzman's Past Insider Trading?

Randall Schatzman's largest purchase order was 1,500 units , worth over $30K on February 9, 2021. In total, Randall Schatzman has made about 4 transactions over 2 years of their time at Bolt Biotherapeutics, Inc. Randall Schatzman usually trades in February, with the busiest year in 2021.

Attention insiders: Dive deeper into market movements and stay ahead of the curve with Benzinga Pro! From up-to-the-second news to audio squawks and interactive data tools, it's everything you need to supercharge your trading strategy. Experience the Benzinga Pro advantage today and transform the way you trade with our exclusive free trial!

Randall Schatzman

Date Range: All Time
Ticker
Type
Value
Price per Share
Shares
Filing Date
No matching records found
Loading...

InsideArbitrage

Our partner InsideArbitrage provides a full suite of tools and analysis that allows you to find opportunities from the hundreds of insiders transactions filed by company insiders each week. The service includes the popular Insider Weekends articles that highlight the top 5 insider purchases and sales each week as well as detailed analysis of one company each week. The service also includes several custom screens such as the Double Dipper that includes a list of companies that are buying back their shares while their insiders are independently buying stock on the open market for their own portfolios.

What is Randall Schatzman's' Mailing Address?

  • Mailing address is 11804 North Creek Parkway South Bothell WA 98011 WA

What are Bolt Biotherapeutics, Inc's Past Insider Trades?

Bolt Biotherapeutics, Inc's most recent insider trade came on July 15, 2022 by Novo Holdings As who sold 800,000 units worth $1.6M . In the last year, insiders at Bolt Biotherapeutics, Inc have sold an estimated value of $1.61M and bought an estimated value of $37.29M worth of shares. Insider trading is most common in February, with the busiest year in 2022. The most active traders at the company are Kathleen Laporte, Director,  William P Quinn, Chief Financial Officer,  and Brian Ocallaghan, Director .

Bolt Biotherapeutics, Inc. Insider Trades

Date Range: All Time
Insider Names
Type
Value
Price per Share
Shares
Filing Date
No matching records found
Loading...